Bioventus(BVS.US) Officer Sells US$14,253.63 in Common Stock
$Bioventus(BVS.US)$ Officer CHURCH KATRINA J sold 2,559 shares of common stock on Jun 21, 2024 at an average price of $5.57 for a total value of $14,253.63.Source: Announcement What is statement of ch
Bioventus(BVS.US) Officer Sells US$32,885.28 in Common Stock
$Bioventus(BVS.US)$ Officer D'Adamio Anthony sold 5,904 shares of common stock on Jun 21, 2024 at an average price of $5.57 for a total value of $32,885.28.Source: Announcement What is statement of ch
Bioventus(BVS.US) Officer Sells US$51,349.83 in Common Stock
$Bioventus(BVS.US)$ Officer Singleton Mark Leonard sold 9,219 shares of common stock on Jun 21, 2024 at an average price of $5.57 for a total value of $51,349.83.Source: Announcement What is statement
Here's Why You Should Consider Buying Bioventus (BVS) Stock
J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Merck (MRK) to Buy Private Ophthalmology Company EyeBio
J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate
Press Release: Inside Information: Alan Donze Has Been Appointed as Bioretec's New CEO
Inside information: Alan Donze has been appointed as Bioretec's new CEO PR Newswire TAMPERE, Finland, May 20, 2024 Bioretec Ltd Inside information 20 May 2024 at 6:00 p.m. EEST TAMPERE, Finland,
Bioventus: Poised for Growth Amidst Strategic Refinement and Debt Reduction
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Shares of AppLovin Corporation (NASDAQ:APP) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.The company posted revenue of $1.
Apyx Medical Corporation Announces Board Leadership Transition
Andrew Makrides Retiring Following More Than 40 Years of Service as Chairman of the Board of Directors; Stavros Vizirgianakis Appointed to Succeed Mr. Makrides as Chairman Apyx Medical Corporation (NASDAQ:APYX) ("Apyx
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Other Big Stocks Moving Lower
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday.Shares of Exact Sciences Corporation (NASDAQ:EXAS) fell sharply in today's pre-market trading aft
Bioventus Price Target Raised to $8.00/Share From $7.00 by Canaccord Genuity
Bioventus Price Target Raised to $8.00/Share From $7.00 by Canaccord Genuity
Bioventus Is Maintained at Buy by Canaccord Genuity
Bioventus Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Bioventus, Raises Price Target to $8
Bioventus Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 61.27% Canaccord Genuity $7 → $8 Maintains Buy 03/13/2024 81.43% Craig-Hallum $6 → $9 Maintains
Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript
Bioventus Inc (BVS) Q1 2024 Earnings Call Transcript Highlights: Strong Start With Significant ...
Q1 2024 Bioventus Inc Earnings Call